http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19990028638-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2875 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-16 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate | 1996-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1999-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-19990028638-A |
| titleOfInvention | Anti-Fas ligand antibody and assay using this antibody |
| abstract | The present invention relates to an anti-Fas ligand antibody and a measurement method using the antibody. To a method for measuring Fas ligand in a human body fluid using an anti-Fas ligand antibody, and to an antibody used in the method. The present invention also relates to an anti-Fas ligand antibody that highly inhibits apoptosis by Fas ligand. The present invention also relates to a hybridoma or cell line producing the antibody.n n n It is an object of the present invention to provide an anti-Fas ligand antibody and a measurement method using the antibody. A method for measuring Fas ligand in human body fluids using an anti-Fas ligand antibody, and an antibody, a measurement reagent and a measurement kit used for the method. In addition, the present invention provides an anti-Fas ligand antibody that inhibits apoptosis by Fas ligand at a high level, for example, 50% or more, and an anti-Fas ligand antibody that is a humanized antibody. The present invention also provides a hybridoma or cell line producing the above antibody. The present invention also provides a composition or medicament comprising at least one of the anti-Fas ligand antibodies of the present invention as an essential component or an effective ingredient, and is useful for the treatment of a disorder characterized by a disorder of Fas antigen / Fas ligand system or an abnormality of apoptosis through Fas antigen A method for treating a systemic or localized pathological condition or disease caused by or more than one or more of the following: a therapeutically effective amount of an anti-Fas ligand antibody that inhibits apoptosis of a Fas antigen expressing cell by a Fas ligand, To a patient. |
| priorityDate | 1995-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 666.